Genomictree (228760) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Genomictree (228760) reported revenue of 3.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20253.8 billion KRW-11.3 billion KRW-9.1 billion KRW[source]
20242.4 billion KRW-15.3 billion KRW-10.4 billion KRW[source]
20233.4 billion KRW-17.3 billion KRW-9.0 billion KRW[source]
202229.9 billion KRW2.4 billion KRW-6.2 billion KRW[source]
20215.1 billion KRW-9.9 billion KRW-11.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025120.6 billion KRW5.3 billion KRW115.3 billion KRW[source]
2024130.3 billion KRW6.2 billion KRW124.0 billion KRW[source]
2023131.7 billion KRW7.0 billion KRW124.7 billion KRW[source]
2022161.6 billion KRW54.6 billion KRW107.1 billion KRW[source]
2021161.4 billion KRW46.3 billion KRW115.1 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice